Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

NuVasive buys Osiris's Osteocel business

Executive Summary

Osiris Therapeutics (stem cell therapies for inflammatory, orthopedic, and cardiovascular indications) has sold NuVasive (minimally invasive devices for spine surgeries) its Osteocel biologics business, including a processing facility.
Deal Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Includes Contract
    • Full Acquisition
    • Includes Earnout

Related Companies

Advertisement
UsernamePublicRestriction

Register